| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/03/2011 | CN102138946A Birch bark extractive as well as preparation method and medical purposes thereof |
| 08/03/2011 | CN102138945A Method of extracting active substances with high content of flavones from ginkgo leaves |
| 08/03/2011 | CN102138941A Precursor liposome of propolis flavone and preparation method thereof |
| 08/03/2011 | CN102138933A Production process of ferrous sulfate sustained-release tablet |
| 08/03/2011 | CN102138921A Application of phthalimide derivatives to preparation of anti-angiogenesis medicaments |
| 08/03/2011 | CN102138910A Atorvastatin calcium tablets and preparation method thereof |
| 08/03/2011 | CN102138888A Alprostadil lipid nanosphere gel and preparation method thereof |
| 08/03/2011 | CN102138593A Formula of lotus leaf fat eliminating and body building tea |
| 08/03/2011 | CN101766706B Medicinal combination containing borneol and musk |
| 08/03/2011 | CN101766705B Medicinal combination containing borneol and musk |
| 08/03/2011 | CN101766704B Medicinal combination containing borneol and musk |
| 08/03/2011 | CN101766700B Medicinal combination containing musk |
| 08/03/2011 | CN101580554B Anoectochilus roxburghii polyose, applications thereof in pharmacy and preparation method of anoectochilus roxburghii polyose |
| 08/03/2011 | CN101371876B Method for extracting and preparing total polysaccharide of compound abnormal savda mature agent |
| 08/03/2011 | CN101293055B Scutellaria health tea and its processing method |
| 08/03/2011 | CN101274033B Medicament composite for diabetes mellitus and preparation method thereof |
| 08/03/2011 | CN101244210B Shencao target fat eliminating essential oil |
| 08/03/2011 | CN101095440B Slimming function of kutin tea and method for manufacturing kutin tea micro-pill |
| 08/03/2011 | CN101028438B Capsule for treating diabetes |
| 08/02/2011 | US7989661 Human ADAM-10 inhibitors |
| 08/02/2011 | US7989634 Melanocortin receptor agonists |
| 08/02/2011 | US7989585 Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 08/02/2011 | US7989492 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidant activity |
| 08/02/2011 | US7989445 Thienopyrimidone compound |
| 08/02/2011 | US7989424 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 08/02/2011 | US7989182 Nucleic acid encoding SCN1A variant |
| 08/02/2011 | CA2608837C Sulfonamide derivatives useful as liver carnitine palmitoyl transferase (l-cpt1) inhibitors |
| 08/02/2011 | CA2583259C Aromatic ring fused pyrimidine derivative |
| 08/02/2011 | CA2489209C New derivatives of arylsulfonamides and use thereof in therapy |
| 08/02/2011 | CA2488242C Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 08/02/2011 | CA2479109C Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 08/02/2011 | CA2478278C Micronutrient supplement |
| 08/02/2011 | CA2463709C N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors |
| 08/02/2011 | CA2458325C Nutritional composition for controlling blood sugar level |
| 08/02/2011 | CA2449634C Somatostatin-dopamine chimeric analogs |
| 08/02/2011 | CA2449298C A coated nicotine-containing chewing gum, manufacture and use thereof |
| 08/02/2011 | CA2449059C Polymer controlled induced viscosity fiber system and uses thereof |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2441690C Method for the identification of antigenic peptides |
| 08/02/2011 | CA2395593C Azaindoles |
| 08/02/2011 | CA2323207C Food products having enhanced cocoa polyphenol content and processes for producing same |
| 08/02/2011 | CA2107569C Parathyroid hormone receptor and dna encoding same |
| 07/28/2011 | WO2011091366A2 Methods of treating or preventing periodontitis and diseases associated with periodontitis |
| 07/28/2011 | WO2011091167A2 Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases |
| 07/28/2011 | WO2011090922A1 Nutritional compensation for western-type diet |
| 07/28/2011 | WO2011090271A2 Composition containing litchi seed extract for preventing or treating fatty liver or obesity |
| 07/28/2011 | WO2011090265A2 Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome |
| 07/28/2011 | WO2011090062A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | WO2011089559A1 A novel polymorphic form of atorvastatin salts |
| 07/28/2011 | WO2011089529A1 Salicylate fatty acid derivatives |
| 07/28/2011 | WO2011089525A2 Chia seed protein concentrate |
| 07/28/2011 | WO2011089416A1 Pyrazine derivatives |
| 07/28/2011 | WO2011089265A1 Use of fatty acid compounds for lowering blood glucose levels |
| 07/28/2011 | WO2011089203A1 Pharmaceutical composition for treating a metabolic syndrome |
| 07/28/2011 | WO2011089170A2 Process for preparing fgf-21 with low degree of o-glycosylation |
| 07/28/2011 | WO2011089168A2 Special composition for the use thereof as a drug |
| 07/28/2011 | WO2011089099A1 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
| 07/28/2011 | WO2011088806A2 A method of industrial production of an amorphous form of atorvastatin with a high specific surface area and its use in a dosage form |
| 07/28/2011 | WO2011088524A1 Methods for regulating blood glucose levels |
| 07/28/2011 | WO2011056037A9 Pharmaceutical composition containing, as active ingredients, lindera erythrocarpa extracts, fractions thereof, or compounds separated from the extracts |
| 07/28/2011 | WO2011038152A3 Toll-like receptor modulators and uses thereof |
| 07/28/2011 | WO2011017516A3 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) |
| 07/28/2011 | WO2010138598A3 Lxr modulators |
| 07/28/2011 | WO2010083034A9 Methods for increasing adiponectin |
| 07/28/2011 | WO2009071283A3 Therapeutic use of desacyl ghrelin |
| 07/28/2011 | US20110185439 G protein coupled receptors and uses thereof |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110184069 Methods and compositions for administration of trpv1 agonists |
| 07/28/2011 | US20110184054 Alpha-lipoic acid concentrate |
| 07/28/2011 | US20110184047 Rnai modulation of scap and therapeutic uses thereof |
| 07/28/2011 | US20110184046 Compositions And Methods For Inhibiting Expression Of GSK-3 Genes |
| 07/28/2011 | US20110184038 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
| 07/28/2011 | US20110184032 Novel Phenylamino Isonicotinamide Compounds |
| 07/28/2011 | US20110184031 G-Protein-Conjugated Receptor Agonist |
| 07/28/2011 | US20110184027 Tissue selective stearoyl-coa desaturase 1 inhibitors and cell based screening assay for their identification |
| 07/28/2011 | US20110184026 C4-substituted alpha-keto oxazoles |
| 07/28/2011 | US20110184020 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions |
| 07/28/2011 | US20110184006 Method and composition for thermally stabilizing vitamin c within nano layers of montmorillonite clay |
| 07/28/2011 | US20110183998 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| 07/28/2011 | US20110183997 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/28/2011 | US20110183994 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 07/28/2011 | US20110183985 Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors |
| 07/28/2011 | US20110183984 Small molecule inhibitors of lck sh2 domain binding |
| 07/28/2011 | US20110183982 Phenoxy acetic acids as ppar delta activators |
| 07/28/2011 | US20110183979 Nitrogen-containing heteroaryl derivatives |
| 07/28/2011 | US20110183977 Benzene, pyridine, and pyridazine derivatives |
| 07/28/2011 | US20110183976 5- and 6-membered heterocyclic compounds |
| 07/28/2011 | US20110183973 Novel Compounds |
| 07/28/2011 | US20110183965 6-aminoisoquinoline compounds |
| 07/28/2011 | US20110183961 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 07/28/2011 | US20110183960 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 07/28/2011 | US20110183958 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 07/28/2011 | US20110183956 Process for the synthesis of ezetimibe and intermediates useful therefor |
| 07/28/2011 | US20110183935 Heartwater |
| 07/28/2011 | US20110183927 Compositions Comprising Sugar-Cysteine Products |
| 07/28/2011 | US20110183919 Novel dipeptidyl peptidase iv (dp-iv) compounds |
| 07/28/2011 | US20110183911 Method for improving neurotransmission failure using a novel agent |
| 07/28/2011 | US20110183902 Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition |
| 07/28/2011 | US20110183901 Superior Control of Blood Glucose in Diabetes Treatment |